GFI1B is an essential transcriptional repressor that plays critical roles in hematopoietic development, particularly in erythroid and megakaryocytic lineages 1. The protein functions as part of a RCOR-GFI-KDM1A-HDAC complex that suppresses genes involved in multilineage blood cell development through histone deacetylase recruitment 2. GFI1B acts primarily as a transcriptional repressor by recruiting histone-modifying enzymes to target gene promoters, though it can function as an activator depending on cellular context 2. During megakaryocytic differentiation, GFI1B directly regulates cytoskeletal proteins Kindlin3 and Talin1, with declining GFI1B levels enabling upregulation of these factors that promote platelet progenitor development 3. Functionally, GFI1B is required for both erythroid and megakaryocytic lineage development, and its loss increases hematopoietic stem cell numbers while reducing their quiescence 1. Disease-wise, GFI1B mutations cause inherited bleeding disorders with low platelet counts and abnormal platelet function 2. Genome-wide association studies have identified GFI1B variants as modulators of myeloproliferative neoplasm risk through effects on hematopoietic stem cell function 4. Additionally, GFI1B shows aberrant expression in autoimmune diseases, contributing to megakaryocyte expansion in rheumatoid arthritis, lupus, and Sjögren's syndrome 5.